PTC Therapeutics | PTCT - El Costo De Ventas





El Costo De Ventas Cambio Fecha
Acadia Pharmaceuticals USD 28.32M 3.52M 2026-06
Alnylam Pharmaceuticals USD 298.45M 87.33M 2026-06
Amgen USD 1.87B 271M 2026-06
BioCryst Pharmaceuticals USD 3.84M 5.68M 2026-06
Biogen USD 945.1M 147.6M 2026-06
BioMarin Pharmaceutical USD 276.29M 76.8M 2026-06
Cytokinetics USD 5.59M 5.43M 2026-06
Daiichi Sankyo JPY 124.29B 6.02B 2026-06
Gilead Sciences USD 1000M 445M 2026-06
Incyte USD 104.96M 457K 2026-06
Ionis Pharmaceuticals USD 2.74M 261K 2026-06
Ironwood Pharmaceuticals USD 29.83M 560K 2024-09
Karyopharm Therapeutics USD 1.34M 139K 2026-03
Novartis USD 3.71B 251M 2026-06
Pfizer USD 4.09B 498M 2026-06
PTC Therapeutics USD 39.61M 23.31M 2026-03
Puma Biotechnology USD 29.1M 18.44M 2024-09
Roche Holding CHF 7.85B 630M 2026-06
Sangamo BioSciences 2.42M 1.11M 2024-06
Sarepta Therapeutics USD 150.1M 40.64M 2026-06
TG Therapeutics USD 41.19M 7.68M 2026-06
Ultragenyx Pharmaceutical USD 30M 1000K 2026-03
Vertex Pharmaceuticals USD 489.2M 96.4M 2026-06
Xencor USD 61.66M 50.95M 2025-06